deltatrials
Completed OBSERVATIONAL NCT02303444

An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors (RIFTOS MKI)

RIFTOS MKI - Radioactive Iodine reFractory Asymptomatic Patients in Differentiated Thyroid Cancer - an Observational Study to Assess the Use of Multikinase Inhibitors

Sponsor: Bayer

Conditions Thyroid Neoplasms
Interventions Other Multikinase inhibitors Sorafenib (Nexavar, BAY43-9006)
Updated 39 times since 2017 Last updated: Jun 7, 2023 Started: Apr 8, 2015 Primary completion: Jun 10, 2020 Completion: Jul 24, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02303444, this observational or N/A phase trial focuses on Thyroid Neoplasms and remains completed. Sponsored by Bayer, it has been updated 39 times since 2015, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Apr 2017 · 3 months · monthly snapshot~Apr 2017 – ~Jun 2017 · 2 months · monthly snapshot~Jun 2017 – ~Dec 2017 · 6 months · monthly snapshot~Dec 2017 – ~Apr 2018 · 4 months · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jun 2020 · 31 days · monthly snapshot~Jun 2020 – ~Jul 2020 · 30 days · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Jul 2023 · 22 months · monthly snapshot~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

39 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jul 2023 — Jul 2024 [monthly]

    Completed

  5. Sep 2021 — Jul 2023 [monthly]

    Completed

▶ Show 34 earlier versions

  1. Jan 2021 — Sep 2021 [monthly]

    Completed

  2. Sep 2020 — Jan 2021 [monthly]

    Completed

    Status: Active Not Recruiting → Completed

  3. Aug 2020 — Sep 2020 [monthly]

    Active Not Recruiting

  4. Jul 2020 — Aug 2020 [monthly]

    Active Not Recruiting

  5. Jun 2020 — Jul 2020 [monthly]

    Active Not Recruiting

  6. May 2020 — Jun 2020 [monthly]

    Active Not Recruiting

  7. Apr 2020 — May 2020 [monthly]

    Active Not Recruiting

  8. Mar 2020 — Apr 2020 [monthly]

    Active Not Recruiting

  9. Feb 2020 — Mar 2020 [monthly]

    Active Not Recruiting

  10. Jan 2020 — Feb 2020 [monthly]

    Active Not Recruiting

  11. Dec 2019 — Jan 2020 [monthly]

    Active Not Recruiting

  12. Nov 2019 — Dec 2019 [monthly]

    Active Not Recruiting

  13. Oct 2019 — Nov 2019 [monthly]

    Active Not Recruiting

  14. Sep 2019 — Oct 2019 [monthly]

    Active Not Recruiting

  15. Aug 2019 — Sep 2019 [monthly]

    Active Not Recruiting

  16. Jul 2019 — Aug 2019 [monthly]

    Active Not Recruiting

  17. Jun 2019 — Jul 2019 [monthly]

    Active Not Recruiting

  18. May 2019 — Jun 2019 [monthly]

    Active Not Recruiting

  19. Apr 2019 — May 2019 [monthly]

    Active Not Recruiting

  20. Mar 2019 — Apr 2019 [monthly]

    Active Not Recruiting

  21. Feb 2019 — Mar 2019 [monthly]

    Active Not Recruiting

  22. Jan 2019 — Feb 2019 [monthly]

    Active Not Recruiting

  23. Dec 2018 — Jan 2019 [monthly]

    Active Not Recruiting

  24. Nov 2018 — Dec 2018 [monthly]

    Active Not Recruiting

  25. Oct 2018 — Nov 2018 [monthly]

    Active Not Recruiting

  26. Sep 2018 — Oct 2018 [monthly]

    Active Not Recruiting

  27. Aug 2018 — Sep 2018 [monthly]

    Active Not Recruiting

  28. Jul 2018 — Aug 2018 [monthly]

    Active Not Recruiting

  29. Jun 2018 — Jul 2018 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  30. Apr 2018 — Jun 2018 [monthly]

    Recruiting

    Phase: NA → None

  31. Dec 2017 — Apr 2018 [monthly]

    Recruiting NA

  32. Jun 2017 — Dec 2017 [monthly]

    Recruiting NA

  33. Apr 2017 — Jun 2017 [monthly]

    Recruiting NA

  34. Jan 2017 — Apr 2017 [monthly]

    Recruiting NA

    First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bayer
Data source: Bayer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States , Atlanta, United States , Aurora, United States , Birmingham, United States , Boston, United States , Chicago, United States , Dallas, United States , Durham, United States , Honolulu, United States , Los Angeles, United States and 24 more locations